chugai

Chugai Pharmabody Research Pte. Ltd. (“CPR”) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Geneo in Singapore, it aims to generate new antibody drugs based on Chugai’s proprietary antibody engineering...

Chugai Pharmabody Research Pte. Ltd. (“CPR”) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Geneo in Singapore, it aims to generate new antibody drugs based on Chugai’s proprietary antibody engineering...

Chugai Pharmabody Research Pte. Ltd. (“CPR”) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Geneo in Singapore , it aims to generate new antibody drugs based on Chugai’s proprietary antibody engineering...

Chugai Pharmabody Research Pte. Ltd. (“CPR”) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Biopolis, (Geneo from September 2026) in Singapore, it aims to generate new antibody drugs based on Chugai’s...

Chugai Pharmabody Research Pte. Ltd. (“CPR”) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Geneo in Singapore, it aims to generate new antibody drugs based on Chugai’s proprietary antibody engineering...

Chugai Pharmabody Research Pte. Ltd. ("CPR") was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Geneo in Singapore , it aims to generate new antibody drugs based on Chugai's proprietary antibody engineering...

Chugai Pharmabody Research Pte. Ltd. ("CPR") was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Geneo in Singapore , it aims to generate new antibody drugs based on Chugai's proprietary antibody engineering...

Chugai Pharmabody Research Pte. Ltd. (“CPR”) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Geneo in Singapore, it aims to generate new antibody drugs based on Chugai’s proprietary antibody engineering...

Chugai Pharmabody Research Pte. Ltd. (“CPR”) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd (Chugai), a member of Roche group, in January 2012 and started operations on July 2, 2012. Located at Biopolis, (Geneo from September 2026) in Singapore , it aims to generate new antibody drugs based on Chugai’s...

Chugai Pharmabody Research Pte. Ltd. in Singapore seeks a Senior Scientist in Lead Optimisation to advance antibody drug candidates. You will drive engineering strategies across humanization, affinity tuning, and developability assessments, collaborating with biology, pharmacology, and manufacturing teams to translate discovery into development. A PhD and...

Chugai Pharmabody Research Pte. Ltd. is seeking a motivated Research Assistant to contribute to drug discovery through peptide and small-molecule synthesis, purification, and analytical activities in the Mid-size Molecule Chemistry Unit. The role involves peptide synthesis, purification by LC, and analyses by LCMS, UPLC and NMR, with opportunities to...

Chugai Pharmabody Research Pte. Ltd. in Singapore seeks a Research Scientist in the Mid-size Molecule Unit. The candidate will lead mid-size molecule projects to identify drug candidates and collaborate with cross-disciplinary teams to deliver innovative drug discovery efforts. Applicants should hold a Ph.D. in Biomedical Science or related field with 3...

Chugai Pharmabody Research Pte. Ltd. (CPR) in Singapore is seeking a Senior Scientist to advance regenerative medicine and CVM drug discovery. You will design and validate cell-based models and assays, lead multidisciplinary projects, and translate findings into therapeutic opportunities. You will work under a Research Manager, collaborate with...

Chugai Pharmabody Research Pte. Ltd. (CPR) invites an IP Leader to join our in-house IP team in Singapore. You will support R&D through patenting strategy, filings, and global prosecution, working closely with Japan and Singapore offices to protect novel antibody technologies. We seek a candidate with 6–8 years of patenting experience in biotechnology or...